Literature DB >> 17157006

Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorhizon.

Sojin An1, Yong-Dae Park, Young-Ki Paik, Tae-Sook Jeong, Woo Song Lee.   

Abstract

Three naphthoquinones were isolated by bioassay-guided fractionation from the CHCl(3) extracts of roots of Lithospermum erythrorhizon. They were identified as acetylshikonin (1), isobutyrylshikonin (2), and beta-hydroxyisovalerylshikonin (3) on the basis of their spectroscopic analyses. The compounds 1-3 were tested for their inhibitory activities against human ACAT-1 (hACAT-1) or human ACAT-2 (hACAT-2). Compound 2 preferentially inhibited hACAT-2 (IC(50)=57.5microM) than hACAT-1 (32% at 120microM), whereas compounds 1 and 3 showed weak inhibitory activities in both hACAT-1 and -2. To develop more potent hACAT inhibitor, shikonin derivatives (5-11) were synthesized by semi-synthesis of shikonin (4), which was prepared by hydrolysis of 1-3. Among them, compounds 5 and 7 exhibited the strong inhibitory activities against hACAT-1 and -2. Furthermore, we demonstrated that compound 7 behaved as a potent ACAT inhibitor in not only in vitro assay system but also cell-based assay system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157006     DOI: 10.1016/j.bmcl.2006.11.024

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Theoretical investigation of the radical scavenging activity of shikonin and acylshikonin derivatives.

Authors:  Ruifa Jin; Yin Bai
Journal:  J Mol Model       Date:  2011-07-15       Impact factor: 1.810

2.  Antiplasmodial and antiproliferative pseudoguaianolides of Athroisma proteiforme from the Madagascar Dry Forest.

Authors:  Ende Pan; Alexander P Gorka; John N Alumasa; Carla Slebodnick; Liva Harinantenaina; Peggy J Brodie; Paul D Roepe; Richard Randrianaivo; Chris Birkinshaw; David G I Kingston
Journal:  J Nat Prod       Date:  2011-10-13       Impact factor: 4.050

3.  Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability.

Authors:  Lina Wang; Zhenzhong Li; Xiangjian Zhang; Sheng Wang; Chunhua Zhu; Jiangyong Miao; Linyu Chen; Lili Cui; Huimin Qiao
Journal:  Neurochem Res       Date:  2013-11-19       Impact factor: 3.996

4.  Shikonin Protects PC12 Cells Against β-amyloid Peptide-Induced Cell Injury Through Antioxidant and Antiapoptotic Activities.

Authors:  Yuna Tong; Lan Bai; Rong Gong; Junlan Chuan; Xingmei Duan; Yuxuan Zhu
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

5.  Developing Phytocompounds from Medicinal Plants as Immunomodulators.

Authors:  Chih-Chun Wen; Hui-Ming Chen; Ning-Sun Yang
Journal:  Adv Bot Res       Date:  2012-06-19       Impact factor: 2.175

6.  Effect of β,β-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo.

Authors:  Yingying Fan; Shaoju Jin; Jun He; Zhenjun Shao; Jiao Yan; Ting Feng; Hong Li
Journal:  Int J Mol Sci       Date:  2012-07-23       Impact factor: 6.208

7.  Shikonin suppresses ERK 1/2 phosphorylation during the early stages of adipocyte differentiation in 3T3-L1 cells.

Authors:  So Young Gwon; Ji Yun Ahn; Chang Hwa Jung; Bo Kyung Moon; Tae Youl Ha
Journal:  BMC Complement Altern Med       Date:  2013-08-06       Impact factor: 3.659

Review 8.  Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.

Authors:  Zhiqin Zhang; Jie Bai; Yawen Zeng; Mengru Cai; Yu Yao; Huimin Wu; Longtai You; Xiaoxv Dong; Jian Ni
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.